Testimony

Every day, AHA staff take to Capitol Hill to tell the hospital story, working to educate Congress on key issues and the field’s concerns. We also advocate with federal regulators, provide expert testimony, and highlight the impact proposed changes could have and suggest alternative solutions. Below are the most recent statements the AHA has submitted for the record for congressional hearings or agency panels.

Latest

Jun 19, 2018
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions regarding “Effective Administration of the 340B Drug Pricing Program.”
Jun 6, 2018
AHA Statement to the Committee on Ways and Means for “Hearing on Lowering Costs and Expanding Access to Health Care through Consumer-Directed Health Plans.”
May 15, 2018
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions: Examining Oversight Reports on the 340B Drug Pricing Program
May 8, 2018
AHA expresses strong support for legislation that would allow responsible sharing of patient substance use disorder (SUD) treatment information and prevent inappropriate
Apr 26, 2018
AHA submit statement before the House Ways and Means Subcommittee on Health.regarding innovative practices and technology in health care. 
Apr 9, 2018
AHA statement before the House Homeland Security Committee on emergency preparedness and lessons learned from Hurricane Harvey.
Mar 21, 2018
The American Hospital Association (AHA) appreciates the opportunity to submit comments on the implementation of alternative payment models (APMs) in the Medicare Access and CHIP Reauthorization Act
Mar 15, 2018
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions Re: Perspectives on the 340B Drug Pricing Program